About 2 results found for searched term "PF-06835919" (0.139 seconds)
Cat.No. | Name | Target |
---|---|---|
M21287 | PF-06835919 | Ketohexokinase |
PF-06835919 is an oral Class I clinical candidate for NAFLD/NASH, targeting ketohexokinase (KHK), an enzyme that initiates fructose metabolism. | ||
M49874 | PF-06835919 | Others |
PF-06835919 |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.